Since the proliferative activity of the breast epithelium is linked to the risk of developing BC in mice (128), the anti-mitogenic activity of IGFBP5 on breast epithelium fits well with the finding that enhancer activities that potentially increase IGFBP5 transcription are associated with lower BC risk (25–27, 129). The gene discussed is IGFBP5; the disease is breast cancer.